Unlearn

You feed Unlearn data from patients in a clinical study, and it returns a digital twin of each participant: an AI-generated simulation that predicts clinical outcomes at every future time point.

Those predictions are produced at the start of a trial, so teams have a forecast for every participant before the study unfolds.

Unlearn is an AI healthcare and data analytics tool for clinical development teams who want to make trial decisions with more confidence.

The company says its digital twin approach reduces the chance of trial failure, cuts costs and shortens timelines.

Those are the vendor's own claims, and no figures are given, so ask for evidence before you commit.

The platform is built around prediction rather than general-purpose analysis.

That focus suits pharmaceutical and biotech researchers running studies, and it is less relevant if you need a broad data tool.

Unlearn sits in the AI research and AI models space, with a narrow job: simulating participant outcomes so trial planning rests on forecasts rather than guesswork.